Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.1600 (1.37%) ($7.9450 - $8.1600) on Tue. Mar. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.31% (three month average) | RSI | 26 | Latest Price | $8.1600(1.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(30%) XLRE(24%) CEMB(20%) IFRA(20%) SDY(20%) | Factors Impacting BCRX price | BCRX will decline at least -1.655% in a week (0% probabilities). VXX(-15%) VIXM(-12%) TLT(-10%) UUP(-8%) PCY(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.655% (StdDev 3.31%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.33(-116.3%) | Resistance Level | $8.61 | 5 Day Moving Average | $8.19(-0.37%) | 10 Day Moving Average | $8.26(-1.21%) | 20 Day Moving Average | $8.61(-5.23%) | To recent high | -31.1% | To recent low | 1.4% | Market Cap | $1.44b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |